Literature DB >> 21682995

Determination of total polyvinylpyrrolidone (PVP) in ophthalmic solutions by size exclusion chromatography with ultraviolet-visible detection.

Panagiotis Tavlarakis1, John J Urban, Nicholas Snow.   

Abstract

A straightforward size exclusion chromatography (SEC) method was developed and validated for the determination of total polivinylpyrrolidone (PVP) in ophthalmic solutions using the unusual combination of size exclusion chromatography (SEC), ultraviolet-visible detection and quantitation of an analyte peak that elutes in the total exclusion volume of the column. Samples of opthalmic solutions are diluted with water and injected onto a TSKgel G1000PW, 7.5 mm i.d. × 30 cm, 12 μm column at 50°C, with 80:20 0.1M sodium acetate-methanol mobile phase and UV detection at 220 nm. Validation was successful for a stability indicating pharmaceutical method, with parameters including specificity, accuracy, linearity, and precision within typical pharmaceutical acceptance criteria. A stress study with acid, base, peroxide, heat, and light indicates that there is no interference from drug, product, or excipients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21682995     DOI: 10.1093/chrsci/49.6.457

Source DB:  PubMed          Journal:  J Chromatogr Sci        ISSN: 0021-9665            Impact factor:   1.618


  3 in total

1.  Structural Basis for the Inhibition of Gas Hydrates by α-Helical Antifreeze Proteins.

Authors:  Tianjun Sun; Peter L Davies; Virginia K Walker
Journal:  Biophys J       Date:  2015-10-20       Impact factor: 4.033

2.  Microencapsulation of amorphous solid dispersions of fenretinide enhances drug solubility and release from PLGA in vitro and in vivo.

Authors:  Kari Nieto; Susan R Mallery; Steven P Schwendeman
Journal:  Int J Pharm       Date:  2020-06-07       Impact factor: 5.875

Review 3.  Activity of Povidone in Recent Biomedical Applications with Emphasis on Micro- and Nano Drug Delivery Systems.

Authors:  Ewelina Waleka; Zbigniew Stojek; Marcin Karbarz
Journal:  Pharmaceutics       Date:  2021-05-04       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.